Durect corporation announces closing of lactel® absorbable polymer product line sale to evonik and receipt of $15 million

Cupertino, calif., jan. 4, 2021 /prnewswire/ -- durect corporation (nasdaq: drrx) today announced that the sale of the lactel product line to evonik closed and the $15 million payment was received on december 31, 2020. about durect corporation durect is a biopharmaceutical company...
DRRX Ratings Summary
DRRX Quant Ranking